Massachusetts General Hospital Hematology Oncology — Boston, Massachusetts

Massachusetts General Hospital Hematology Oncology is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Hematology Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Uveal Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Hematology Oncology?

Massachusetts General Hospital Hematology Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Hematology Oncology conducted?

Massachusetts General Hospital Hematology Oncology has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Uveal Melanoma.

Is Massachusetts General Hospital Hematology Oncology accredited by Crixeo Health?

Massachusetts General Hospital Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.